{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:44:48Z","timestamp":1767141888388,"version":"build-2238731810"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11011-016-9820-3","type":"journal-article","created":{"date-parts":[[2016,3,20]],"date-time":"2016-03-20T21:15:20Z","timestamp":1458508520000},"page":"849-857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-0760","authenticated-orcid":false,"given":"Salim Yalcin","family":"Inan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burak Cem","family":"Soner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Saide","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"9820_CR1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pain.2009.07.012","volume":"146","author":"DK Ahn","year":"2009","unstructured":"Ahn DK, Lee SY, Han SR, Ju JS, Yang GY, Lee MK, Youn DH, Bae YC (2009) Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats. Pain 146:114\u2013120","journal-title":"Pain"},{"key":"9820_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(08)70291-6","volume":"8","author":"AL Benabid","year":"2009","unstructured":"Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson\u2019s disease. Lancet Neurol 8:67\u201381","journal-title":"Lancet Neurol"},{"key":"9820_CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","volume":"2","author":"E Bezard","year":"2001","unstructured":"Bezard E, Brotchie JM, Gross CE (2001) Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2:577\u2013588","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 2","key":"9820_CR4","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.parkreldis.2008.04.015","volume":"14","author":"F Blandini","year":"2008","unstructured":"Blandini F, Armentero MT, Martignoni E (2008) The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord 14(Suppl 2):S124\u2013S129","journal-title":"Parkinsonism Relat Disord"},{"key":"9820_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.05.021","volume":"85C","author":"A Borrajo","year":"2014","unstructured":"Borrajo A, Rodriguez-Perez AI, Villar-Cheda B, Guerra MJ, Labandeira-Garcia JL (2014) Inhibition of the microglial response is essential for the neuroprotective effects of rho-kinase inhibitors on MPTP-induced dopaminergic cell death. Neuropharmacology 85C:1\u20138","journal-title":"Neuropharmacology"},{"key":"9820_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","volume":"211","author":"J Bove","year":"2012","unstructured":"Bove J, Perier C (2012) Neurotoxin-based models of Parkinson\u2019s disease. Neuroscience 211:51\u201376","journal-title":"Neuroscience"},{"key":"9820_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2006.04.042","volume":"541","author":"K Buyukafsar","year":"2006","unstructured":"Buyukafsar K, Yalcin I, Kurt AH, Tiftik RN, Sahan-Firat S, Aksu F (2006) Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice. Eur J Pharmacol 541:49\u201352","journal-title":"Eur J Pharmacol"},{"key":"9820_CR8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1037\/a0023167","volume":"125","author":"JF Castro-Alvarez","year":"2011","unstructured":"Castro-Alvarez JF, Gutierrez-Vargas J, Darnaudery M, Cardona-Gomez GP (2011) ROCK inhibition prevents tau hyperphosphorylation and p25\/CDK5 increase after global cerebral ischemia. Behav Neurosci 125:465\u2013472","journal-title":"Behav Neurosci"},{"key":"9820_CR9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.expneurol.2005.08.011","volume":"196","author":"CC Chan","year":"2005","unstructured":"Chan CC, Khodarahmi K, Liu J, Sutherland D, Oschipok LW, Steeves JD, Tetzlaff W (2005) Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury. Exp Neurol 196:352\u2013364","journal-title":"Exp Neurol"},{"key":"9820_CR10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311:1670\u20131683","journal-title":"JAMA"},{"key":"9820_CR11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbrc.2004.08.004","volume":"322","author":"PK Dash","year":"2004","unstructured":"Dash PK, Orsi SA, Moody M, Moore AN (2004) A role for hippocampal rho-ROCK pathway in long-term spatial memory. Biochem Biophys Res Commun 322:893\u2013898","journal-title":"Biochem Biophys Res Commun"},{"key":"9820_CR12","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.neuropsychologia.2009.07.022","volume":"47","author":"M Denheyer","year":"2009","unstructured":"Denheyer M, Kiss ZH, Haffenden AM (2009) Behavioral effects of subthalamic deep brain stimulation in Parkinson\u2019s disease. Neuropsychologia 47:3203\u20133209","journal-title":"Neuropsychologia"},{"key":"9820_CR13","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1523\/JNEUROSCI.22-15-06570.2002","volume":"22","author":"P Dergham","year":"2002","unstructured":"Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, McKerracher L (2002) Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 22:6570\u20136577","journal-title":"J Neurosci"},{"key":"9820_CR14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303\u2013317","journal-title":"Exp Neurol"},{"key":"9820_CR15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.expneurol.2005.12.002","volume":"198","author":"CI Dubreuil","year":"2006","unstructured":"Dubreuil CI, Marklund N, Deschamps K, McIntosh TK, McKerracher L (2006) Activation of rho after traumatic brain injury and seizure in rats. Exp Neurol 198:361\u2013369","journal-title":"Exp Neurol"},{"key":"9820_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbr.2012.02.034","volume":"231","author":"SM Fleming","year":"2012","unstructured":"Fleming SM, Schallert T, Ciucci MR (2012) Cranial and related sensorimotor impairments in rodent models of Parkinson\u2019s disease. Behav Brain Res 231:317\u2013322","journal-title":"Behav Brain Res"},{"key":"9820_CR17","doi-asserted-by":"publisher","unstructured":"Geiger, BM, Frank, LE, Caldera-Siu, AD, Pothos, EN (2008) Survivable stereotaxic surgery in rodents. J Vis Exp doi: 10.3791\/880","DOI":"10.3791\/880"},{"key":"9820_CR18","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/jm901618d","volume":"53","author":"B Ghosh","year":"2010","unstructured":"Ghosh B, Antonio T, Reith ME, Dutta AK (2010) Discovery of 4-(4-(2-((5-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)Ethyl)piperaz in-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2\/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson\u2019s disease. J Med Chem 53:2114\u20132125","journal-title":"J Med Chem"},{"key":"9820_CR19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","volume":"230","author":"KE Glajch","year":"2012","unstructured":"Glajch KE, Fleming SM, Surmeier DJ, Osten P (2012) Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson\u2019s disease. Behav Brain Res 230:309\u2013316","journal-title":"Behav Brain Res"},{"key":"9820_CR20","first-page":"304","volume":"8","author":"R G\u00fcnther","year":"2014","unstructured":"G\u00fcnther R, Saal KA, Suhr M, Scheer D, Koch JC, B\u00e4hr M, Lingor P, T\u00f6nges L (2014) The rho kinase inhibitor Y-27632 improves motor performance in male SOD1-G93A mice. Front Neurosci 8:304","journal-title":"Front Neurosci"},{"key":"9820_CR21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0361-9230(97)00449-8","volume":"46","author":"JM Henderson","year":"1998","unstructured":"Henderson JM, Dunnett SB (1998) Targeting the subthalamic nucleus in the treatment of Parkinson\u2019s disease. Brain Res Bull 46:467\u2013474","journal-title":"Brain Res Bull"},{"key":"9820_CR22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/bjp.2008.225","volume":"155","author":"SY Inan","year":"2008","unstructured":"Inan SY, Buyukafsar K (2008) Antiepileptic effects of two rho-kinase inhibitors, Y-27632 and fasudil, in mice. Br J Pharmacol 155:44\u201351","journal-title":"Br J Pharmacol"},{"key":"9820_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pnpbp.2014.10.008","volume":"57","author":"SY Inan","year":"2015","unstructured":"Inan SY, Soner BC, Sahin AS (2015) Infralimbic cortex rho-kinase inhibition causes antidepressant-like activity in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 57:36\u201343","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9820_CR24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/01.RES.0000079941.59846.D4","volume":"92","author":"K Ito","year":"2003","unstructured":"Ito K, Hirooka Y, Sakai K, Kishi T, Kaibuchi K, Shimokawa H, Takeshita A (2003) Rho\/rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension. Circ Res 92:1337\u20131343","journal-title":"Circ Res"},{"key":"9820_CR25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.HYP.0000177119.23178.05","volume":"46","author":"K Ito","year":"2005","unstructured":"Ito K, Hirooka Y, Hori N, Kimura Y, Sagara Y, Shimokawa H, Takeshita A, Sunagawa K (2005) Inhibition of rho-kinase in the nucleus tractus solitarius enhances glutamate sensitivity in rats. Hypertension 46:360\u2013365","journal-title":"Hypertension"},{"key":"9820_CR26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/emm.2004.14","volume":"36","author":"SJ Kim","year":"2004","unstructured":"Kim SJ, Jeon S, Shin EY, Kim EG, Park J, Bae CD (2004) AMPA, not NMDA, activates RhoA GTPases and subsequently phosphorylates moesin. Exp Mol Med 36:98\u2013102","journal-title":"Exp Mol Med"},{"key":"9820_CR27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","volume":"152","author":"D Kirik","year":"1998","unstructured":"Kirik D, Rosenblad C, Bjorklund A (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152:259\u2013277","journal-title":"Exp Neurol"},{"key":"9820_CR28","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1523\/JNEUROSCI.20-12-04686.2000","volume":"20","author":"D Kirik","year":"2000","unstructured":"Kirik D, Rosenblad C, Bjorklund A, Mandel RJ (2000) Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson\u2019s model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci 20:4686\u20134700","journal-title":"J Neurosci"},{"key":"9820_CR29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbr.2008.05.023","volume":"195","author":"A Kucuk","year":"2008","unstructured":"Kucuk A, Golgeli A, Saraymen R, Koc N (2008) Effects of age and anxiety on learning and memory. Behav Brain Res 195:147\u2013152","journal-title":"Behav Brain Res"},{"key":"9820_CR30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nbd.2009.06.011","volume":"36","author":"M Li","year":"2009","unstructured":"Li M, Huang Y, Ma AA, Lin E, Diamond MI (2009) Y-27632 improves rotarod performance and reduces huntingtin levels in R6\/2 mice. Neurobiol Dis 36:413\u2013420","journal-title":"Neurobiol Dis"},{"key":"9820_CR31","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1152\/physrev.00021.2012","volume":"93","author":"G Loirand","year":"2013","unstructured":"Loirand G, Sauzeau V, Pacaud P (2013) Small G proteins in the cardiovascular system: physiological and pathological aspects. Physiol Rev 93:1659\u20131720","journal-title":"Physiol Rev"},{"key":"9820_CR32","doi-asserted-by":"crossref","first-page":"7148","DOI":"10.1523\/JNEUROSCI.14-11-07148.1994","volume":"14","author":"EI Miklyaeva","year":"1994","unstructured":"Miklyaeva EI, Castaneda E, Whishaw IQ (1994) Skilled reaching deficits in unilateral dopamine-depleted rats: impairments in movement and posture and compensatory adjustments. J Neurosci 14:7148\u20137158","journal-title":"J Neurosci"},{"key":"9820_CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd1719","volume":"4","author":"BK Mueller","year":"2005","unstructured":"Mueller BK, Mack H, Teusch N (2005) Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 4:387\u2013398","journal-title":"Nat Rev Drug Discov"},{"key":"9820_CR34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1471-4159.2003.01784.x","volume":"86","author":"M Narita","year":"2003","unstructured":"Narita M, Takagi M, Aoki K, Kuzumaki N, Suzuki T (2003) Implication of rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats. J Neurochem 86:273\u2013282","journal-title":"J Neurochem"},{"key":"9820_CR35","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMct1208070","volume":"367","author":"MS Okun","year":"2012","unstructured":"Okun MS (2012) Deep-brain stimulation for Parkinson\u2019s disease. N Engl J Med 367:1529\u20131538","journal-title":"N Engl J Med"},{"key":"9820_CR36","doi-asserted-by":"crossref","first-page":"e11236","DOI":"10.1371\/journal.pone.0011236","volume":"5","author":"KT Ota","year":"2010","unstructured":"Ota KT, Monsey MS, Wu MS, Schafe GE (2010) Synaptic plasticity and NO-cGMP-PKG signaling regulate pre- and postsynaptic alterations at rat lateral amygdala synapses following fear conditioning. PLoS One 5:e11236","journal-title":"PLoS One"},{"key":"9820_CR37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","volume":"20","author":"A Parent","year":"1995","unstructured":"Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. II. the place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128\u2013154","journal-title":"Brain Res Brain Res Rev"},{"key":"9820_CR38","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San Diego","edition":"4"},{"key":"9820_CR39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2010.02.003","volume":"210","author":"F Rauch","year":"2010","unstructured":"Rauch F, Schwabe K, Krauss JK (2010) Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model. Behav Brain Res 210:46\u201353","journal-title":"Behav Brain Res"},{"key":"9820_CR40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nbd.2013.06.004","volume":"58","author":"AI Rodriguez-Perez","year":"2013","unstructured":"Rodriguez-Perez AI, Dominguez-Meijide A, Lanciego JL, Guerra MJ, Labandeira-Garcia JL (2013) Inhibition of rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson\u2019s disease. Neurobiol Dis 58:209\u2013219","journal-title":"Neurobiol Dis"},{"key":"9820_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0466-4","volume":"188","author":"A Saitoh","year":"2006","unstructured":"Saitoh A, Yamada M, Yamada M, Kobayashi S, Hirose N, Honda K, Kamei J (2006) ROCK inhibition produces anxiety-related behaviors in mice. Psychopharmacology 188:1\u201311","journal-title":"Psychopharmacology"},{"key":"9820_CR42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/toxsci\/kfn092","volume":"104","author":"M Sanchez","year":"2008","unstructured":"Sanchez M, Gastaldi L, Remedi M, Caceres A, Landa C (2008) Rotenone-induced toxicity is mediated by rho-GTPases in hippocampal neurons. Toxicol Sci 104:352\u2013361","journal-title":"Toxicol Sci"},{"key":"9820_CR43","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","volume":"39","author":"T Schallert","year":"2000","unstructured":"Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777\u2013787","journal-title":"Neuropharmacology"},{"key":"9820_CR44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A (2004) Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res 318:215\u2013224","journal-title":"Cell Tissue Res"},{"key":"9820_CR45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1083\/jcb.200506136","volume":"172","author":"V Schubert","year":"2006","unstructured":"Schubert V, Da Silva JS, Dotti CG (2006) Localized recruitment and activation of RhoA underlies dendritic spine morphology in a glutamate receptor-dependent manner. J Cell Biol 172:453\u2013467","journal-title":"J Cell Biol"},{"key":"9820_CR46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","volume":"50","author":"RK Schwarting","year":"1996","unstructured":"Schwarting RK, Huston JP (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. analysis of functional deficits, recovery and treatments. Prog Neurobiol 50:275\u2013331","journal-title":"Prog Neurobiol"},{"key":"9820_CR47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/FJC.0b013e3182a3718f","volume":"62","author":"J Shi","year":"2013","unstructured":"Shi J, Wei L (2013) Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil. J Cardiovasc Pharmacol 62:341\u2013354","journal-title":"J Cardiovasc Pharmacol"},{"key":"9820_CR48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s13311-010-0007-z","volume":"8","author":"AJ Stoessl","year":"2011","unstructured":"Stoessl AJ (2011) Neuroimaging in Parkinson\u2019s disease. Neurotherapeutics 8:72\u201381","journal-title":"Neurotherapeutics"},{"key":"9820_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jneumeth.2005.04.023","volume":"151","author":"ME Sughrue","year":"2006","unstructured":"Sughrue ME, Mocco J, Komotar RJ, Mehra A, D\u2019Ambrosio AL, Grobelny BT, Penn DL, Connolly ES Jr. (2006) An improved test of neurological dysfunction following transient focal cerebral ischemia in rats. J Neurosci Methods 151:83\u201389","journal-title":"J Neurosci Methods"},{"key":"9820_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nlm.2011.08.007","volume":"97","author":"S Sweetat","year":"2012","unstructured":"Sweetat S, Rosenblum K, Lamprecht R (2012) Rho-associated kinase in the gustatory cortex is involved in conditioned taste aversion memory formation but not in memory retrieval or relearning. Neurobiol Learn Mem 97:1\u20136","journal-title":"Neurobiol Learn Mem"},{"key":"9820_CR51","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/NEN.0000000000000095","volume":"73","author":"L Tatenhorst","year":"2014","unstructured":"Tatenhorst L, Tonges L, Saal KA, Koch JC, Szego EM, Bahr M, Lingor P (2014) Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease. J Neuropathol Exp Neurol 73:770\u2013779","journal-title":"J Neuropathol Exp Neurol"},{"key":"9820_CR52","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1093\/brain\/aws254","volume":"135","author":"L Tonges","year":"2012","unstructured":"Tonges L, Frank T, Tatenhorst L, Saal KA, Koch JC, Szego EM, Bahr M, Weishaupt JH, Lingor P (2012) Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson\u2019s disease. Brain 135:3355\u20133370","journal-title":"Brain"},{"key":"9820_CR53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","volume":"367","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69\u201393","journal-title":"Acta Physiol Scand Suppl"},{"key":"9820_CR54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","volume":"24","author":"U Ungerstedt","year":"1970","unstructured":"Ungerstedt U, Arbuthnott GW (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24:485\u2013493","journal-title":"Brain Res"},{"key":"9820_CR55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2046-4053-2-33","volume":"2","author":"HM Vesterinen","year":"2013","unstructured":"Vesterinen HM, Currie GL, Carter S, Mee S, Watzlawick R, Egan KJ, Macleod MR, Sena ES (2013) Systematic review and stratified meta-analysis of the efficacy of RhoA and rho kinase inhibitors in animal models of ischaemic stroke. Syst Rev 2:33","journal-title":"Syst Rev"},{"key":"9820_CR56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s002130050309","volume":"131","author":"V Volke","year":"1997","unstructured":"Volke V, Soosaar A, Koks S, Bourin M, Mannisto PT, Vasar E (1997) 7-nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology 131:399\u2013405","journal-title":"Psychopharmacology"},{"key":"9820_CR57","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.bbadis.2010.05.002","volume":"1802","author":"A Wirth","year":"2010","unstructured":"Wirth A (2010) Rho kinase and hypertension. Biochim Biophys Acta 1802:1276\u20131284","journal-title":"Biochim Biophys Acta"},{"key":"9820_CR58","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.3760\/cma.j.issn.0366-6999.20111068","volume":"126","author":"BQ Wu","year":"2013","unstructured":"Wu BQ, Bi ZG, Qi Q (2013) Inactivation of the rho-ROCK signaling pathway to promote neurologic recovery after spinal cord injuries in rats. Chin Med J 126:3723\u20133727","journal-title":"Chin Med J"}],"updated-by":[{"DOI":"10.1007\/s11011-016-9846-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T00:00:00Z","timestamp":1464393600000}}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-016-9820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-016-9820-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-016-9820-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:36:49Z","timestamp":1718411809000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-016-9820-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["9820"],"URL":"https:\/\/doi.org\/10.1007\/s11011-016-9820-3","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}